Link to the source article >> https://healthpolicy-watch.news/africa-unions-400-million-jj-vaccine/
Eleven African countries will this weekend start receiving their portion of the first batch of 400 million COVID-19 vaccines from Johnson and Johnson (J&J), the Africa CDC announced on Thursday.
Recipients include Togo, Lesotho, Ghana, Tunisia, Angola, Cameroon, Egypt, Botswana, Nigeria, Ethiopia and Mauritius, and they are part of pool purchasing facilitated by the African Union (AU) and African Vaccine Acquisition Trust (AVAT) to AU member states. Six Carribean communities including Jamaica, Barbados, Guyana, St Kitts & Nevis, Trinidad &Tobago and the Bahamas will also have doses delivered next week.
The delivery of the lifesaving drug comes as 32 of the continent’s 55 countries are battling a third wave of COVID-19 infections, 25 of which are experiencing a “severe third wave”.
However, the target of vaccinating 60% of Africa’s population by the end of 2022 might not be enough to protect the continent, Dr John Nkengasong, Director of the Africa Centres for Disease Control and Prevention (Africa CDC), said during the centre’s weekly COVID-19 briefing.
Africa will now need to vaccinate 75% to 80% of people, taking into consideration several factors, including the different virus variants and the continent’s population structure, according to Nkengasong. The initial target of 60% was partly based on the assumption that 40% of the population was 18 and under and that they would not need to be vaccinated as they will “immediately come down with a disease.”
“We now know that anybody is vulnerable now… those young people are falling sick and they are dying and that needs to be factored into a new projection,” said Nkengasong. However, he said that the continent will in the meantime aim for the 60% target after which a possible adjustment will be made based on “the biology and the pathogenesis of the variants”.
Return to the list of articlesWe are waiting for you!
Join us, it’s really easy! Contact us, you or your Relatives and we will advise you on how you can benefit from our support.